Overview

In this white paper, we review transferable lessons from the bioprocessing industry to gene therapy processing.

There are many lessons to learn from traditional biologics like vaccines and mAbs as they have been early adopters of aseptic connectors and single-use technologies (SUT) overall. Some of the main benefits that led to SUT adoption are cost savings, speed to delivery and sterility

Learn how your gene therapy manufactures can benefit from the lessons learned from biologics to determine if these techniques could help improve your productivity and quality.